| # | Drug | Count |
|---|---|---|
| 0 | FENTANYL | 33 |
| 1 | BUPIVACAINE | 24 |
| 2 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 24 |
| 3 | MORPHINE | 23 |
| 4 | ATROPINE SULFATE | 17 |
| 5 | MORPHINE SULFATE | 17 |
| 6 | BUPIVACAINE HYDROCHLORIDE | 16 |
| 7 | ATROPINE | 12 |
| 8 | PHENYLEPHRINE HYDROCHLORIDE | 12 |
| 9 | FENTANYL CITRATE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 24 | 0.0031 |
| 1 | ATROPINE SULFATE INJECTION | 7 | 0.0028 |
| 2 | ATROPINE SULFATE MONOHYDRATE | 7 | 0.0028 |
| 3 | BUPIVACAINE | 24 | 0.0026 |
| 4 | EPHEDRINE HYDROCHLORIDE | 1 | 0.0022 |
| 5 | SUFENTANIL CITRATE | 1 | 0.0008 |
| 6 | NARATRIPTAN | 1 | 0.0007 |
| 7 | EDARAVONE | 1 | 0.0006 |
| 8 | FENTANYL CITRATE | 10 | 0.0006 |
| 9 | REMIFENTANIL HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Opioid Agonist [EPC] | 34 |
| 1 | Amide Local Anesthetic [EPC] | 24 |
| 2 | Anticholinergic [EPC] | 12 |
| 3 | Cholinergic Muscarinic Antagonist [EPC] | 12 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 10 |
| 6 | Corticosteroid [EPC] | 9 |
| 7 | Catecholamine [EPC] | 5 |
| 8 | beta-Adrenergic Blocker [EPC] | 5 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-1 Adrenergic Agonist [EPC] | 10 | 0.0023 |
| 1 | Anticholinergic [EPC] | 12 | 0.0007 |
| 2 | Cholinergic Muscarinic Antagonist [EPC] | 12 | 0.0003 |
| 3 | Amide Local Anesthetic [EPC] | 24 | 0.0003 |
| 4 | Opioid Agonist [EPC] | 34 | 0.0001 |
| 5 | Catecholamine [EPC] | 5 | 0.0001 |
| 6 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 7 | General Anesthetic [EPC] | 1 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | beta-Adrenergic Blocker [EPC] | 5 | 0.0000 |